AstraZeneca / Renovis: Cerovive offers hope in stroke market.
In: PharmaWatch: Monthly Review, Jg. 3 (2004-12-01), Heft 12, S. 12-12
report
Zugriff:
Announces the continuity of Renovis Inc.'s clinical trials of the stroke drug Cerovive. Possibility of having a successful study on Cerovive; Clinical description of the drug; Presentation on the study of the drug's safety and efficacy.
Titel: |
AstraZeneca / Renovis: Cerovive offers hope in stroke market.
|
---|---|
Zeitschrift: | PharmaWatch: Monthly Review, Jg. 3 (2004-12-01), Heft 12, S. 12-12 |
Veröffentlichung: | 2004 |
Medientyp: | report |
Schlagwort: |
|
Sonstiges: |
|